Dental Association of PEI Presents

Cannabis: The Future and your Practice

Saturday, January 26^th, 2019 Delta Charlottetown

8:00am – 4:30pm

 

Course registration fees

On or before January 2^nd, 2019: $175.00 Dentists, $75.00 Auxiliaries.  After January 2^nd, 2019: $210.00 Dentists, $90.00 Auxiliaries

 

8:00-8:30am – Arrival and coffee

 

Speakers

8:30-9:00am – Edwin Jewell, Canada’s Island Garden, FIGR East, President,

“Farming a New Crop”

 

9:00-10:30am – Karen Campbell, Q.C.

    The seminar will focus on helping employers to navigate the impact of cannabis in the workplace. It will examine the key differences in the legislative regimes for medical and recreational cannabis use, as well as, discuss some of the potential effects both may have on workplaces. The seminar will also address the main components of workplace policies dealing with cannabis, the challenge of detecting cannabis impairment, appropriate discipline, and when the employer’s duty to accommodate medical cannabis use is triggered.

 

10:30am-12:00pm – Peter R. Ford BScPharm, Pharm D; Owner of Ford’s Family

Brief history of cannabis and cannabinoids 

• Introductory overview of the endocannabinoid system 

• Endocannabinoid system pharmacology and cannabinoid interactions with other systems e.g. opiates 

• Update on cannabinoid medications (Medical cannabis under ACMPR and Health Canada approved drugs) available in Canada 

• Update on ongoing clinical trials 

• Cannabis use syndrome and vulnerable populations

 

12:00-1:00pm – Luncheon Buffet

 

1:00-2:30pm – Aurelia De Pauw, M.Sc., Ph.D., Director Clinical Program/Medical Affairs at Tetra bio-pharma

   Cannabis beneficial effects have been observed in a large range of indications, such as muscle relaxation, rheumatic and chronic pains, anxiety, depression, loss of appetite, childhood-onset epilepsy and chemotherapy-induced vomiting and nausea. However, cannabinoid-based medicines are still not appropriately integrated into clinical practice due to a lack of evidence on safety, efficacy and administration instructions. Tetra Bio-Pharma has developed several formulations of Cannabis and is currently running preclinical and clinical trials to collect high-quality data on cannabinoid-based medicines.

    Tetra Bio-Pharma will present the safety and pharmacokinetics data of inhaled cannabis and cannabis oil collected in Health Canada-approved phase I studies. An overview of on-going phases II and III clinical trials with different formulations of cannabis will be presented too. The clinical studies will highlight the complexity of cannabis treatment, related to the targeted patient population and the complexity of the dosage and formulation to treat a particular health condition.

 

2:30-4:30pm – Dr. Aaron Burry, CDA, Associate Director, Professional Affairs

 

Dental Considerations related to Cannabis:  implications for dental practice.   In terms of my own expertise I have worked in a public setting for over 30 years.   I worked with many individuals who have both social, mental health and substance use issues.  This is part of my daily practice.     

• What does cannabis use in Canada look like today?  What should I understand as a dentist about that?
•  Disclosure – updating medical history and discussions to include questions related to cannabis.
• Prescribing verses authorization:  how is legalization going to change?
• Oral health impacts of cannabis – what do we see in long term use and smoking?
• What are the benefits of cannabis?
• Tobacco smoking, cannabis and now nicotine vaping solutions:  new ball game.
• Common scenarios:  how to have a conversation with patients about cannabis use and its potential impact for them – safer alternatives?
• Making sure we provide care safely.

-----------------------------------------------------------------------------------------------------------------------

Invitation to attend the Scleroderma Canada Education Forum

November 24th, Halifax NS

 It is with great pleasure that we extend you an invitation to attend the Scleroderma Education Forum taking place on November 24, 2018 at the Four Points by Sheraton, Halifax, NS.

 

Scleroderma Canada’s Education Forum is an opportunity for those living with this rare auto-immune disease; their families; clinicians; and other stakeholders who share an interest in systemic sclerosis to come together in an interactive format. An expert panel will provide a wealth of information on a wide variety of topics. Presenters will include Dr. Evelyn Sutton, Rheumatologist, who will speak to the manifestations of scleroderma; Dr. Brett Thombs of SPIN will share information regarding online support tools; Dr. Murray Baron of the CSRG will discuss stem cell transplantation; and more. Following the panel, there will be a question & answer session with the forum audience.

 

As a health-related organization with ties to the scleroderma community, we believe you will find tremendous value in the conversations that will take place at this event.

 

 

REGISTRATION IS FREE! 

 

12:00pm – Light Lunch

1:00pm – Forum Panel

 

Four Points by Sheraton

1496 Hollis Street, Halifax NS

 

To register, please visit www.scleroderma.ca

 

 

Should you have any questions, please contact us at info@sclerodermanovascotia.ca. We look forward to welcoming you on November 24^th.

 

Regards,

 

Jason Doucette

President, Scleroderma Society of Nova Scotia

---------------------------------------------------------------------------------------------------------------------------------------

CDHA Summit

REGISTRATION NOW OPEN

----------------------------------------------------------------------------------

PEIDHA is pleased to present a Continuing Dental Education Course

Tobacco, E-Cigarettes and Nicotine 101

When: Saturday May 12, 2018 from 8:30 am to 10:30 am (2 CE credits)

-----------------------------------------------------------------------------------------------------------------------------------------------------